Latest research in post-transplant cyclophosphamide in matched unrelated versus haploidentical donors, outcomes in patients with AITL, and high molecular weight kininogen in acetaminophen-induced liver injury

episode

Blood Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

The Ezra Klein Show: Jensen Huang Thinks A.I. Alarmism Has Gone Too Far 1h 50m · 25 Sep 2026 · Hard Fork

What If We’ve Missed the Beauty of Sex? | The Gospels | Matthew 5:27–32 16 min · 25 Sep 2026 · Ten Minute Bible Talks Devotional Bible Study

Trump’s Standoff With White House Reporters, and the Rise and Fall of ‘Pervert Glasses’ 14 min · 25 Sep 2026 · The Headlines

Green Demon - Classic 34 min · 25 Sep 2026 · Spooked

Trump Unleashes Secret Biblical Strategy Against Xi Jinping 22 min · 25 Sep 2026 · Politics By Faith w/Mike Slater

Big meet, little meat: the Trump-Xi summit 27 min · 25 Sep 2026 · Economist Podcasts

Report any issue

Source

Recorded22 Jul 2021

Publisherfeeds.transistor.fm ↗

Handlerec:11742131

Show notes

In this week’s episode, we will learn more about the use of high-dose post-transplant cyclophosphamide in matched unrelated donors versus HLA haploidentical grafts, review prognostic factors and outcomes from the largest cohort of patients with angioimmunoblastic T-cell lymphoma reported to date, and look at a study that suggests that high molecular weight kininogen contributes to acetaminophen-induced liver injury.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in